Diagnosis and Treatment of Hepatitis B in Traditional Chinese and Western Medicine

Author: Tan Xinghua
Publisher:
Publish Date: 2005-07-01
Features: Hepatitis B Virus (HBV) infection is a significant public health issue and a major cause of death from infectious diseases worldwide. In China, there are approximately 120 million people positive for surface antigen (HBsAg), over 30 million chronic hepatitis B patients, and 270,000 deaths annually from hepatitis B-related liver diseases. This places a severe burden on society and families, making it a very prominent and critical issue in modern society. In recent years, significant progress has been made in research on the prevention and treatment of hepatitis B. The combined use of recombinant hepatitis B vaccine and high-efficiency hepatitis B immune globulin; the gradual development of artificial liver and liver transplantation technologies; the increasing clinical use of interferon; the introduction of nucleoside analogs such as lamivudine and adefovir; the continuous advancement of immune preparations; and the development of gene therapy research have all advanced the treatment of chronic hepatitis B. Additionally, the use of various anti-fibrosis drugs developed through long-term clinical experience in traditional Chinese medicine has provided possibilities for blocking the progression of liver cirrhosis and even reversing it. This book comprehensively introduces the etiology, pathogenesis, epidemiological characteristics, diagnosis, treatment, dietary management, and preventive methods of hepatitis B from both Western and traditional Chinese medicine perspectives. To some extent, it reflects the current understanding of hepatitis B virus infection and aims to provide clinical learning and reference for.